Article
Publicly Available
Frontmatter
Published/Copyright:
January 17, 2022
Published Online: 2022-01-17
©2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Minireviews
- Characteristics and management of asymptomatic SARS-CoV-2 infections
- Perspectives into the possible effects of the B.1.1.7 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on spermatogenesis
- Antibody-dependent enhancement of virus infection and disease: implications in COVID-19
- Reviews
- A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19
- Increase in SARS-CoV-2 infected biomedical waste among low middle-income countries: environmental sustainability and impact with health implications
- A dossier on COVID-19 chronicle
- Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility
- Original Articles
- COVID-19 infection in children with underlying malignancies in Iran
- Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method
- COVID-19 disease in clinical setting: impact on gonadal function, transmission risk, and sperm quality in young males
- Hydroxychloroquine pre-exposure prophylaxis provides no protection against COVID-19 among health care workers: a cross-sectional study in a tertiary care hospital in North India
- Letter to the Editors
- The “Delta Plus” COVID-19 variant has evolved to become the next potential variant of concern: mutation history and measures of prevention
- Can sulfasalazine as an old drug with immunomodulatory and anti‐inflammatory effects be effective in COVID‐19?
- Using of calcium channel blockers in patients with COVID-19: a magic bullet or a double-edged sword?
Articles in the same Issue
- Frontmatter
- Minireviews
- Characteristics and management of asymptomatic SARS-CoV-2 infections
- Perspectives into the possible effects of the B.1.1.7 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on spermatogenesis
- Antibody-dependent enhancement of virus infection and disease: implications in COVID-19
- Reviews
- A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19
- Increase in SARS-CoV-2 infected biomedical waste among low middle-income countries: environmental sustainability and impact with health implications
- A dossier on COVID-19 chronicle
- Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility
- Original Articles
- COVID-19 infection in children with underlying malignancies in Iran
- Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method
- COVID-19 disease in clinical setting: impact on gonadal function, transmission risk, and sperm quality in young males
- Hydroxychloroquine pre-exposure prophylaxis provides no protection against COVID-19 among health care workers: a cross-sectional study in a tertiary care hospital in North India
- Letter to the Editors
- The “Delta Plus” COVID-19 variant has evolved to become the next potential variant of concern: mutation history and measures of prevention
- Can sulfasalazine as an old drug with immunomodulatory and anti‐inflammatory effects be effective in COVID‐19?
- Using of calcium channel blockers in patients with COVID-19: a magic bullet or a double-edged sword?